Patients with Stage III and IV HCC (n = 91) were chosen and 90 patients with ATXN1 data available were divided into low-ATXN1 and high-ATXN1 groups (Figure 9a). The gene discussed is ATXN1; the disease is hepatocellular carcinoma.